Biome Grow Inc
Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.
Biome Grow Inc (BIOIF) - Net Assets
Latest net assets as of September 2023: $-4.82 Million USD
Based on the latest financial reports, Biome Grow Inc (BIOIF) has net assets worth $-4.82 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($130.28K) and total liabilities ($4.95 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-4.82 Million |
| % of Total Assets | -3698.86% |
| Annual Growth Rate | N/A |
| 5-Year Change | -129.45% |
| 10-Year Change | N/A |
| Growth Volatility | 53233.76 |
Biome Grow Inc - Net Assets Trend (2013–2022)
This chart illustrates how Biome Grow Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Biome Grow Inc (2013–2022)
The table below shows the annual net assets of Biome Grow Inc from 2013 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-4.42 Million | -168.78% |
| 2021-12-31 | $6.43 Million | -1.34% |
| 2020-12-31 | $6.52 Million | -5.82% |
| 2019-12-31 | $6.92 Million | -53.91% |
| 2018-12-31 | $15.01 Million | +161165.76% |
| 2017-12-31 | $9.31K | +104.28% |
| 2016-12-31 | $-217.28K | -129.05% |
| 2015-12-31 | $748.05K | +1006.86% |
| 2014-12-31 | $67.58K | +800.99% |
| 2013-12-31 | $7.50K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Biome Grow Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3017479700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $23.18 Million | % |
| Other Comprehensive Income | $2.58 Million | % |
| Total Equity | $-4.42 Million | 100.00% |
Biome Grow Inc Competitors by Market Cap
The table below lists competitors of Biome Grow Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sonovia Ltd
TA:SONO
|
$37.36K |
|
MONROE CAP.CORP. DL -001
F:6JT
|
$37.39K |
|
London Security Plc
LSE:LSC
|
$37.42K |
|
DAIRY FARM INTL (DFA1.SG)
STU:DFA1
|
$37.43K |
|
COMPUTER MODELLING
BE:5TJ
|
$37.31K |
|
LHC
VN:LHC
|
$37.30K |
|
Hadasit Bio
TA:HDST
|
$37.28K |
|
C3is Inc.
NASDAQ:CISS
|
$37.22K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Biome Grow Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 6,428,737 to -4,421,416, a change of -10,850,153 (-168.8%).
- Net loss of 10,887,311 reduced equity.
- Other comprehensive income increased equity by 37,158.
- Other factors decreased equity by 0.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.89 Million | -246.24% |
| Other Comprehensive Income | $37.16K | +0.84% |
| Total Change | $- | -168.78% |
Book Value vs Market Value Analysis
This analysis compares Biome Grow Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.00 | $0.00 | x |
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.15 | $0.00 | x |
| 2019-12-31 | $0.06 | $0.00 | x |
| 2020-12-31 | $0.06 | $0.00 | x |
| 2021-12-31 | $0.06 | $0.00 | x |
| 2022-12-31 | $-0.04 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Biome Grow Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (55.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -701.95% | 0.00% | 0.00x | 3.67x | $-481.15K |
| 2015 | -506.38% | 0.00% | 0.00x | 1.06x | $-3.86 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.02 Million |
| 2017 | 1906.07% | 0.00% | 0.00x | 1.00x | $184.64K |
| 2018 | -59.03% | 0.00% | 0.00x | 1.04x | $-10.36 Million |
| 2019 | -137.02% | -202.63% | 0.34x | 1.98x | $-10.17 Million |
| 2020 | -3.67% | 0.00% | 0.00x | 1.93x | $-890.83K |
| 2021 | -2.18% | 0.00% | 0.00x | 1.72x | $-782.80K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-10.45 Million |
Industry Comparison
This section compares Biome Grow Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Biome Grow Inc (BIOIF) | $-4.82 Million | -701.95% | N/A | $37.31K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |